Get our Free Patent Expiration Newsletter

Serving leading biopharmaceutical companies globally:

AstraZeneca
Harvard Business School
Johnson and Johnson
Medtronic
Express Scripts
McKinsey

Last Updated: November 18, 2019

DrugPatentWatch Database Preview

Luliconazole - Generic Drug Details

See Plans and Pricing

« Back to Dashboard

What are the generic sources for luliconazole and what is the scope of freedom to operate?

Luliconazole is the generic ingredient in one branded drug marketed by Medicis and is included in one NDA. There are five patents protecting this compound. Additional information is available in the individual branded drug profile pages.

Luliconazole has sixty-four patent family members in twenty-five countries.

There are six drug master file entries for luliconazole. Two suppliers are listed for this compound.

Summary for luliconazole
Drug Prices for luliconazole

See drug prices for luliconazole

Recent Clinical Trials for luliconazole

Identify potential brand extensions & 505(b)(2) entrants

SponsorPhase
Valeant PharmaceuticalsPhase 4
Valeant Pharmaceuticals International, Inc.Phase 4
Bausch & Lomb IncorporatedPhase 4

See all luliconazole clinical trials

Pharmacology for luliconazole
Synonyms for luliconazole
(-)-(E)-((4R)-4-(2,4-Dichlorophenyl)-1,3-dithiolan-2-ylidene)(1H-imidazol-1-yl)acetonitrile
(2E)-2-[(4R)-4-(2,4-dichlorophenyl)-1,3-dithiolan-2-ylidene]-2-imidazol-1-yl-acetonitrile
(2E)-2-[(4R)-4-(2,4-dichlorophenyl)-1,3-dithiolan-2-ylidene]-2-imidazol-1-ylacetonitrile
(R,E)-2-(4-(2,4-dichlorophenyl)-1,3-dithiolan-2-ylidene)-2-(1H-imidazol-1-yl)acetonitrile
164L198
187164-19-8
1H-Imidazole-1-acetonitrile, alpha-((4R)-4-(2,4-dichlorophenyl)-1,3-dithiolan-2-ylidene)-, (alphaE)-
2-[(2E,4R)-4-(2,4-dichlorophenyl)-1,3-dithiolan-2-ylidene]-2-(1H-imidazol-1-yl)acetonitrile
4-(2,4-Dichlorophenyl)-1,3-dithiolan-2-ylidene-1-imidazolylacetonitrile
AC1MHEOF
AK543859
AKOS015897320
AM84645
AN-15036
BCP9000863
C13478
CAS-187164-19-8
CHEBI:34825
CHEMBL2105689
CS-0587
D01980
DB08933
DS-3278
DSSTox_CID_28533
DSSTox_GSID_48607
DSSTox_RID_82805
DTXSID3048607
GTPL7366
HY-14283
Imidazole antimycotic
Lulicon
Lulicon (TN)
Lulicon|||NND 502
Luliconazole (JAN/USAN/INN)
Luliconazole [USAN:INN]
Luliconazole, >=98% (HPLC)
Luzu
Luzu (TN)
MolPort-035-395-835
NCGC00182704-01
NCGC00182704-02
NCGC00182704-03
NND 502
NND-502
NND502
PR-2699
RE91AN4S8G
s4258
SB18987
SCHEMBL342362
SR-01000945039
SR-01000945039-1
SW219226-1
Tox21_112942
Tox21_112974
Tox21_112974_1
UNII-5JA16R08FJ component YTAOBBFIOAEMLL-REQDGWNSSA-N
UNII-RE91AN4S8G
W-5249
ZINC3929486

US Patents and Regulatory Information for luliconazole

Applicant Tradename Generic Name Dosage NDA Approval Date TE Type RLD RS Patent No. Patent Expiration Product Substance Delist Req. Exclusivity Expiration
Medicis LUZU luliconazole CREAM;TOPICAL 204153-001 Nov 14, 2013 RX Yes Yes   Start Trial   Start Trial Y   Start Trial
Medicis LUZU luliconazole CREAM;TOPICAL 204153-001 Nov 14, 2013 RX Yes Yes   Start Trial   Start Trial   Start Trial
Medicis LUZU luliconazole CREAM;TOPICAL 204153-001 Nov 14, 2013 RX Yes Yes   Start Trial   Start Trial Y   Start Trial
>Applicant >Tradename >Generic Name >Dosage >NDA >Approval Date >TE >Type >RLD >RS >Patent No. >Patent Expiration >Product >Substance >Delist Req. >Exclusivity Expiration

Make Better Decisions: Try a trial or see plans & pricing

Serving leading biopharmaceutical companies globally:

Colorcon
Merck
Baxter
Boehringer Ingelheim
Mallinckrodt
Medtronic

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verifification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.